Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population

Trial Identifier:	D9612R00010
Sponsor:	AstraZeneca
NCTID::	NCT03118778
Start Date:	April 2017
Primary Completion Date:	July 2017
Study Completion Date:	July 2017
Condition:	Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Beijing, China, 100013

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.